AIV
46
3
KMB
28
-2
ZBH
71
6
NAVI
33
-2
V
42
-8
AMAT
44
-4
TSN
20
-2
MNST
45
-4
TDC
55
-5
PX
50
-9
AAL
54
3
LB
69
5
LMT
25
-4
SO
40
-13
NDAQ
52
-4
PSX
24
-5
PHM
37
-4
FE
38
-6
ICE
42
-4
EQR
31
-2
AIV
46
3
KMB
28
-2
ZBH
71
6
NAVI
33
-2
V
42
-8
AMAT
44
-4
TSN
20
-2
MNST
45
-4
TDC
55
-5
PX
50
-9
AAL
54
3
LB
69
5
LMT
25
-4
SO
40
-13
NDAQ
52
-4
PSX
24
-5
PHM
37
-4
FE
38
-6
ICE
42
-4
EQR
31
-2
Financhill
Back

ProShares UltraPro S&P500 Vs. Intra-Cellular Therapies Industry Stock Comparison

Sell
19

UPRO
ProShares UltraPro S&P500

Last Price:
$85.76
Seasonality Move:
9.33%
Sell
42

ITCI
Intra-Cellular Therapies

Last Price:
$94.86
Seasonality Move:
2.9%
Sell
19
ProShares UltraPro S&P500 (UPRO) is a Sell

Is ProShares UltraPro S&P500 a Buy, Sell or Hold?

  • The current ProShares UltraPro S&P500 [UPRO] share price is $85.70. The Score for UPRO is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • UPRO is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
42
Intra-Cellular Therapies (ITCI) is a Sell

Is Intra-Cellular Therapies a Buy, Sell or Hold?

  • The current Intra-Cellular Therapies [ITCI] share price is $94.87. The Score for ITCI is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • ITCI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

UPRO Stock Price Chart

What is ProShares UltraPro S&P500's stock price today?

  • The ProShares UltraPro S&P500 share price today is $85.70
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and UPRO is experiencing slight selling pressure.

ITCI Stock Price Chart

What is Intra-Cellular Therapies's stock price today?

  • The Intra-Cellular Therapies share price today is $94.87
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ITCI is experiencing slight buying pressure.

UPRO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.54 Sell
Relative Strength Index (14 RSI): 37.41 Sell
Chaikin Money Flow: -4081638 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (89.59 - 98.35) Sell
Bollinger Bands (100): (81.42 - 94.62) Sell

ITCI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.52 Buy
Relative Strength Index (14 RSI): 71.02 Buy
Chaikin Money Flow: 1717350 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (82.26 - 87.1) Buy
Bollinger Bands (100): (74.04 - 85.96) Buy

UPRO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 89.4 Sell
20-day SMA: 92.8 Sell
50-day SMA: 92.89 Sell
200-day SMA: 79.89 Buy
8-day EMA: 89.68 Sell
20-day EMA: 91.74 Sell
50-day EMA: 91.63 Sell
200-day EMA: 80.57 Buy

ITCI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 84.68 Buy
20-day SMA: 84.71 Buy
50-day SMA: 85.48 Buy
200-day SMA: 75.72 Buy
8-day EMA: 85.91 Buy
20-day EMA: 85.03 Buy
50-day EMA: 83.75 Buy
200-day EMA: 76.64 Buy

ProShares UltraPro S&P500 Earnings Growth & UPRO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Intra-Cellular Therapies Earnings Growth & ITCI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.92 per share, and an increase next year of $3.25 per share.

ProShares UltraPro S&P500 Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Intra-Cellular Therapies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):